Tuesday, August 29, 2017

FDA approves new antibacterial drug - FDA Press Releases

The U.S. Food and Drug Administration today approved Vabomere for adults with complicated urinary tract infections (cUTI), including a type of kidney infection, pyelonephritis, caused by specific bacteria. Vabomere is a drug containing meropenem, an antibacterial, and vaborbactam, which inhibits certain types of resistance mechanisms used by bacteria.

from Food and Drug Administration--Press Releases http://ift.tt/2wmxcrg
via IFTTT

No comments:

Post a Comment